Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer

Anne‐Marie Chaftari(The University of Texas MD Anderson Cancer Center), Issam Raad(Missouri Department of Agriculture), Bruno Granwehr(The University of Texas MD Anderson Cancer Center), Ray Hachem(The University of Texas MD Anderson Cancer Center), George M. Viola(The University of Texas MD Anderson Cancer Center), Ammar Yousif(The University of Texas MD Anderson Cancer Center), Kumait Garoge(The University of Texas MD Anderson Cancer Center), Ying Jiang(The University of Texas MD Anderson Cancer Center), Aline El Zakhem(The University of Texas MD Anderson Cancer Center), Mary Jordan(The University of Texas MD Anderson Cancer Center), Andrew Gagel(The University of Texas MD Anderson Cancer Center), Zainab Al Hamal(The University of Texas MD Anderson Cancer Center), Victor E. Mulanovich(The University of Texas MD Anderson Cancer Center), Ruth Reitzel(The University of Texas MD Anderson Cancer Center)
Antimicrobial Agents and Chemotherapy
October 20, 2015
Cited by 10


Related Papers